[LGND] YoY Quarter Result on 30-Jun-2020 [#Q2]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
07-Aug-2020
Financial Year
2020
Quarter
30-Jun-2020 [#Q2]
Profit Trend
QoQ- 191.53%
YoY- 253.17%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Revenue 26,366 57,419 84,675 41,420 24,987 90,043 27,995 -0.99%
PBT 3,171 -636 33,301 28,119 -18,028 95,579 8,300 -14.81%
Tax 881 259 2,576 6,033 -3,609 22,419 2,242 -14.41%
NP 2,290 -895 30,725 22,086 -14,419 73,160 6,058 -14.96%
Tax Rate -27.78% - -7.74% -21.46% - -23.46% -27.01% -
Total Cost 24,076 58,314 53,950 19,334 39,406 16,883 21,937 1.56%
Ratio Analysis
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
NP Margin 8.69 -1.56 36.29 53.32 -57.71 81.25 21.64 -14.10%
Per Share
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
EPS 0.13 -0.05 1.84 1.38 -0.74 3.45 0.29 -12.51%
EPS Diluted 0.13 -0.05 1.79 1.32 -0.74 2.99 0.26 -10.90%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.